Matthew T David is Chief Financial Officer of CorMedix Inc.. Currently has a direct ownership of 47,934 shares of CRMD, which is worth approximately $495,158. The most recent transaction as insider was on Jan 12, 2024, when has been sold 5,216 shares (Common Stock) at a price of $3.47 per share, resulting in proceeds of $18,099. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.9K
0% 3M change
1421.71% 12M change
Total Value Held $495,158

Matthew T David Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 12 2024
SELL
Payment of exercise price or tax liability
$18,099 $3.47 p/Share
5,216 Reduced 9.81%
47,934 Common Stock
Jan 12 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 48.47%
53,150 Common Stock
Dec 06 2021
BUY
Open market or private purchase
$4,500 $4.5 p/Share
1,000 Added 24.1%
3,150 Common Stock
Dec 06 2021
BUY
Open market or private purchase
$4,500 $4.5 p/Share
1,000 Added 24.1%
3,150 Common Stock
Nov 17 2021
BUY
Open market or private purchase
$5,070 $5.07 p/Share
1,000 Added 31.75%
2,150 Common Stock
MTD

Matthew T David

Chief Financial Officer
Berkeley Heights, NJ

Track Institutional and Insider Activities on CRMD

Follow CorMedix Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRMD shares.

Notify only if

Insider Trading

Get notified when an Cor Medix Inc. insider buys or sells CRMD shares.

Notify only if

News

Receive news related to CorMedix Inc.

Track Activities on CRMD